Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Nanoform Finland Oyj is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in API Manufacturing, Sterile Fill/Finish, Lyophilization
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Finland
Founded:2000
Employees:1,079
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
International Regulatory
EU GMP Certificates
2
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval HLEGGE
FDA · #APR-S05PYE34 · 2022-06-01
Drug Approval EEDQN1
FDA · #APR-TBVU5I4L · 2022-03-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-Q6TTB0E3
Issued: 2020-05-25
Expires: 2025-10-15
WHO GMP
World Health Organization
Cert #: CERT-0LC448QY
Issued: 2020-11-21
Expires: 2025-05-22
Loading CDMO intelligence...
Key facts about Nanoform Finland Oyj
- Nanoform Finland Oyj is headquartered in Finland.
- Nanoform Finland Oyj was founded in 2000.
- Nanoform Finland Oyj has 1,079 employees.
- Nanoform Finland Oyj's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Nanoform Finland Oyj
Directory pages this company appears in, each with the full list of matching manufacturers.